The research report tender’s in-depth analysis of the Protein Expression Market size, revenue, market share, major market segments, and different geographic regions, the Future forecast for the next five years. Global market prospects on different topics such as market scope, market analysis by end users. Manufacturing cost analysis, Industrial Chain, Sourcing Strategy and Downstream Buyers, Market Effect Factors.
The protein expression market is segmented on the basis of systems type, product, application,
and end user.
Protein expression is a technique or methodology in which proteins are characterized, modified, and synthesized in the host cells. The selected protein is typically achieved by the modification or alteration of the protein expression process in a living cell. Various kinds of protein expression systems are used to produce a broad range of therapeutic proteins such as insulin, interferons, and interleukins.
Protein Expression Market Based on Product;
On the basis of product, the market is segmented into competent cells, expression vectors, instruments, reagents, and services. The reagents segment is expected to hold the largest market share of the protein expression market. This is primarily due to the increasing protein expression research activities and the large-scale production of antibodies and vaccines.
Protein Expression Market Based on Application;
By application, the protein expression market is segmented into therapeutic applications, research applications and industrial applications. The therapeutic applications segment is expected to account for the largest share of the market in 2017. The growth in this segment is primarily attributed to increasing prevalence of chronic diseases such as cancer and diabetes around the world.
The objectives of this study are as follows:
Speak to Our Research Expert:
Major Key Players in Protein Expression Market;
Key players operating in the protein expression market include Merck KGaA (Germany), Thermo Fisher Scientific Inc. (U.S.), Becton, Dickinson & Company (U.S.), Agilent Technologies, Inc. (U.S.), QIAGEN N.V. (Netherlands), Takara Bio Inc. (Japan), Lonza Group Ltd. (Switzerland), Bio-Rad Laboratories, Inc. (U.S.), GenScript Biotech Corporation (China), Lucigen Corporation (U.S.), Synthetic Genomics Inc. (U.S.), Promega Corporation (U.S.), New England Biolabs, Inc. (U.S.), Sengenics (Singapore.), ARTES Biotechnology GmbH (Germany), Addgene Inc. (U.S.) , LifeSensors Inc. (U.S.)
We just sent you an email. Please click the link in the email to confirm your subscription!
OKSubscriptions powered by Strikingly